Intraoperative Case Series Study: Trial Rasp Position Versus SL-PLUS™ MIA Ti/HA Femoral Hip Stem Position
NCT ID: NCT02664272
Last Updated: 2019-07-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2016-04-06
2017-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft
NCT04036071
Safety and Efficacy of the SL PLUS and the SL PLUS MIA Hip Stem
NCT01435850
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NCT04943328
The Viability of Short Stems in Total Hip Arthroplasty
NCT02577822
Comparative Study of Minimally Invasive Surgical Approaches for Total Hip Arthroplasty
NCT04311125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total Hip Arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* requires primary THA with the SL-PLUS™ MIA Ti/HA femoral hip stem
* is at least 21 years of age at the time of surgery
* is skeletally mature in the PI's judgment
* has consented to participate in the study by signing the EC approved ICF
Exclusion Criteria
* requires the use of a ceramic-on-ceramic bearing
* has infections, acute or chronic, local or systemic
* has severe muscle, nerve or vascular diseases that endanger the respective limb
* has lack of bone substance or defective bone quality that jeopardizes the stable seating of the prosthesis
* has any concomitant disease that may jeopardize implant function
* has a known allergy to study device or one or more of its components
* requires a revision surgery and has extensive bone defects
* has diagnosis of an immunosuppressive disorder
* is pregnant
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew Orthopaedics AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andy Weymann, MD, MBA
Role: STUDY_DIRECTOR
Smith & Nephew Orthopaedics AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinik für Orthopädie, PMU Salzburg
Salzburg, , Austria
Charité Universitätsmedizin Berlin Centrum für Muskuloskeletale Chirurgie Klinik für Orthopädie
Berlin, , Germany
Orthopädische Chirurgie München
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SL MIA rasp 15-4567-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.